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Introduction: The effectiveness of screening colonoscopy in decreasing the incidence of 
colorectal cancer (CRC) is largely dependent on the detection of polyps and the quality of the 
procedure. Several key quality measures have been proposed to improve the effectiveness of 
screening colonoscopies.
Aim: To evaluate quality indicators of screening colonoscopy in a tertiary hospital.
Methods: All CRC screening colonoscopies performed between 2005 and 2009 in a single 
tertiary center were reviewed for internationally accepted quality measures.
Results: Of the 1545 individuals who underwent first-time screening colonoscopy 38% were 
male and 62% were female. The mean age of the patients was 60.4 years and the mean   difference 
in ages was ± 10.3 years. Cecal intubation rate was 91% (1336), however ileocecal valve photo 
documentation was performed in only 81% (1248) colonoscopies. The quality of bowel   preparation 
was classified as: good 76% (1171), reasonable 11% (174), and poor 13% (200). Polyp detec-
tion rate (PDR) was 33% (503). The prevalence of polyps $1 cm in size was 5% (82). PDR was 
significantly higher in men than in women (44% [260] vs 25% [243], P = 0.0001). Other factors 
significantly influencing PDR were quality of bowel preparation (odds ratio [OR]: 1.28, 95% 
confidence interval [CI]: 0.9–1.6) and age over 50 (OR: 1.9, 95% CI: 1.3–2.9). Left colonic polyps 
were associated with a risk ratio of 2.3 (95% CI: 1.8–2.9) of lesions in the other colonic segments 
compared to no polyps in the left colon. None of the colonoscopists reported withdrawal time.
Conclusion: Cecal intubation rate and quality of bowel preparation were suboptimal. The polyp 
detection rate compares favorably to accepted standards and its main determinants are male sex, 
age .50 years, quality of bowel preparation, and the presence of left colonic polyps.
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Introduction
The incidence of colorectal cancer (CRC) is rising in Europe and it is estimated 
that every year more than 400,000 patients are newly diagnosed with CRC.1 Most 
cancers grow relatively slowly over 10–15 years and the development of CRC is 
attributed to the adenoma–carcinoma sequence.2 This window period allows for 
screening and prevention of CRC by endoscopic removal of polyps. Many experts 
and scientific societies advocate colonoscopy as the method of choice for screening 
and prevention of CRC.3–5 Although there is good evidence for the positive impact in 
the reduction of CRC it is also recognized that its effectiveness is dependent on the 
quality of the procedure6–8 which, unfortunately, is very variable in the clinical prac-
tice. A number of key quality indicators have been recommended. In 2002, quality 
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Endoscopy/American College of Gastroenterology (ASGE/
ACG) and further adjusted by Rex et al.8,9 The key indicators 
proposed were: preprocedure (appropriate indication and use 
of surveillance intervals, informed consent); intraprocedure 
(documentation of quality of bowel preparation, cecal intu-
bation rates with photodocumentation of cecal landmarks, 
adenoma detection rate, withdrawal time .6 minutes, 
adequate resection of polyps); postprocedure (measurement 
of incidence of perforation, post-polypectomy bleeding and 
nonoperative management of post-polypectomy bleeding). 
Lieberman was the lead author of the report of the Quality 
Assurance Task Group of the National Colorectal Cancer 
Roundtable that developed a reporting and data system for 
colonoscopy to assist endoscopists in monitoring quality 
indicators in their practice.10 European guidelines for quality 
assurance in CRC screening and diagnosis have recently been 
published.11 Most CRC screening programs now incorporate 
routine assessment of the quality of examinations as a way 
to improve screening colonoscopy clinical outcomes. The 
quality of colonoscopies cannot be measured or improved if 
reports do not include key quality indicators. The objectives 
of our study were (1) to determine if screening colonoscopy 
reports in our center included key quality indicators and (2) to 
measure the actual performance of our examinations when 
compared to accepted standards.
Methods
We retrospectively analyzed all colonoscopy reports of 
the examinations performed between 2005 and 2009 in 
our Gastroenterology Department which we coded in our 
database as screening colonoscopies for CRC. Only total 
colonoscopies (as intended) where included. All of the 
examinations were performed by board-certified specialists 
or fellows in training. A total of 1545 first-time screening 
colonoscopies were eligible for data analysis. Procedure-
related quality indicators considered for analysis were: cecal 
intubation rate and photodocumentation of cecal landmarks 
(ileocecal valve, appendiceal orifice, or terminal ileum), 
quality of bowel preparation, and polyp detection rate. The 
quality of bowel preparation was subjectively classified at the 
time of the examination by each endoscopist as good, fair, or 
poor, so we adopted these three grades of bowel preparation. 
The polyp detection rate instead of adenoma detection rate 
was considered since we did not have pathology data for all 
of the examinations. Accordingly, polyps $10 mm were 
considered surrogate markers for advanced neoplasia.12 
We correlated polyp detection rate with sex and age 
(dichotomized as ,50 vs $50 years old), quality of bowel 
preparation, and use of sedation. Statistical analysis was 
performed using Microsoft Excel (Microsoft Corp, Redmond, 
WA) and SAS software (v 9.1; SAS Institute, Inc, Cary, 
NC). Multivariate analysis was used to determine factors 
influencing the polyp detection rate. A value of P , 0.05 
was considered significant.
Results
The patient demographics are shown in Table 1. A total of 
1545 examinations corresponding to 1545 patients were 
made. The distribution according to gender was 62% female 
and 38% male. The mean age of the patients was 60.4 years 
and the mean difference in ages was ± 10.3 years. Seventy 
percent of the patients were between 50 and 70 years old. 
Cecal intubation was successful in 91% (1336) of the 
colonoscopies although documentation of either three of 
the landmarks considered was present in only 81% (1248). 
Incomplete colonoscopies accounted for 14% (209) of the 
examinations. The motives for incomplete colonoscopy were 
patient intolerance 40% (84), inadequate bowel preparation 
35% (73), technical difficulties 18% (37), and obstructive 
lesion 0.5% (1). A second screening colonoscopy within the 
same year was performed on only 30% (62) of patients with 
incomplete colonoscopies, of which 40% had polyps.
The quality of bowel preparation was classified as: good 
76% (1171), fair 11% (174), and poor 13% (200). There 
was no significant gender difference in the quality of bowel 
preparation. Sixty-seven percent (1046) of the colonosco-
pies were performed without sedation, 25% (392) under 
conscious sedation, and 7% (107) under deep sedation. 
Although there were more incomplete examinations due to 
intolerance in patients without sedation than in patients with 
Table 1 Patient characteristics
Gender N (%)
Male 587 (38)
Female 958 (62)
Age (years) Median
Patients 60.4 (±10.3)
Male 64.9 (±9.8)
Female 60.1 (±10.5)
Age, stratified N (%)
20–29 14 (0.9)
30–40 34 (2.2)
40–50 119 (7.7)
50–60 548 (35.5)
60–70 552 (35.7)
70–80 225 (14.6)
80–90 40 (2.6)
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conscious sedation (6% [64] vs 5% [19]), the difference was 
not   significant (P = 0.31).
The overall polyp detection rate (PDR) was 33% (503). 
The prevalence of polyps $10 mm in size, a surrogate 
marker for advanced neoplasia, was 5% (82). The polyp 
distribution was as follows: left colon 74% (370), right colon 
31% (153), and transverse colon 17% (86) patients. In 26% 
(98) of the patients with left colonic polyps, synchronous 
polyps in the transverse or right colon were also detected. 
The presence of left colonic polyps was associated with a 
risk ratio of 2.3 (95% confidence interval [CI]: 1.8–2.9) for 
lesions in other colonic segments compared to no polyps in 
the left colon. Male gender was a major risk factor for the 
presence of polyps. PDR was significantly higher in men 
than in women (44% [260] vs 25% [243], P = 0.0001) with 
an odds ratio [OR] of 2.3 (95% CI: 1.8–2.9). Men also had 
a significantly higher prevalence of polyps $1 cm (9% [50] 
vs 3% [32], P = 0.002) and multiple polyps (22% [126] vs 
11% [105], P = 0.0001), compared to women. Polyps were 
more frequently detected in patients aged $50 years than 
in those ,50 years (34% vs 20%, P = 0.0004). PDR was 
higher in patients with good bowel preparation compared 
to reasonable or poor bowel preparation (34% vs 28%, OR: 
1.28, 95% CI: 0.9–1.6). Polyps where detected in 34% of 
colonoscopies with deep/conscious sedation compared to 
32% in colonoscopies without sedation but this difference 
was not significant (P = 0.38). Colorectal cancer was found 
in 0.3% (five) patients (three men and two women, mean age 
68 years). Of these, two (40%) had at least one synchronous 
polyp, both in the left colon.
Discussion
Colonoscopy has become accepted as a powerful screening 
tool for CRC prevention and early diagnosis since 2000, 
when two landmark articles13,14 were published describing 
results of screening colonoscopy and its feasibility and ability 
to provide definitive insights into the types and locations of 
important advanced neoplastic lesions that would be missed 
with sigmoidoscopy. Although the efficacy of colonoscopy 
in reducing CRC incidence and mortality is well established, 
there are some major pitfalls. Firstly, the positive impact of 
colonoscopy is largely operator-dependent,6,8,18 highlighting 
the importance of the quality of the procedure. Secondly, 
colonoscopy seems to provide more protection against 
distal rather than proximal colon cancer, as pointed out by 
Canadian case-control and cohort studies.15–18 The relative 
ineffectiveness of screening colonoscopy in the prevention 
of proximal colon cancer might be explained by certain 
biological features of neoplasms at this level19 but also by 
potentially correctable factors related to the quality of the 
examination. The importance of defining and establishing 
uniform quality benchmarks for screening colonoscopy as a 
way to overcome these pitfalls and assure the positive impact 
of this examination has been recognized. In our study we 
analyzed some of the key quality indicators for screening 
colonoscopies and compared them to the proposed standards 
by ASGE/ACG8,9 as a first step to improve our practice.
Completion rates have been proposed as a quality metric 
because it is reasonable to assume that the effectiveness of 
colonoscopy is limited if the entire colon is not routinely 
examined. Cecal intubation is defined as passing the tip of the 
endoscope beyond the ileocecal valve lip. Photodocumentation 
is recommended and important from a medical-legal 
perspective. Our observed cecal intubation rate (91%) is 
suboptimal compared to the ASGE benchmark of 95%. 
Variations in cecal intubation rates are due to physician variables 
(skill including dexterity, training level), patient variables (age, 
gender, body mass index, past surgeries, tortuousity of the 
colon, pain threshold, and response to anesthesia), and the 
adequacy of bowel preparation.20–22 In our study we found that 
there were two main factors which contributed to incomplete 
colonoscopies. Firstly, patient intolerance in 40% (84) was 
the major motive for an incomplete examination. Because 
of logistical restrictions the majority of the colonoscopies 
where performed without sedation (67%) and this may have 
contributed to a high incidence of patient intolerance. Secondly, 
there was a higher incidence than desirable of patients with 
poor bowel preparation (13%).
A major limitation of our study was the subjective 
assessment of bowel preparation. The perception of good, 
fair, or poor between our endoscopists is highly variable 
and only a few report the quality of preparation if it is 
poor. We considered such reports to be indicative of good 
bowel preparation. The ASGE guidelines recommend that 
documentation of bowel preparation should be done in every 
examination. Although there is no standardized system for 
this, an adequate preparation is one that allows the clear 
detection of lesions .5 mm. The percentage of examinations 
with poor bowel preparation should be less than 10%,9 a 
benchmark which we did not achieve. This should warn 
us to give special attention to our implemented bowel 
preparation protocol. Recent studies have shown that split 
dose polyethylene glycol-electrolyte (PEG) is more effective 
than conventional bowel preparations23 and that adherence to 
dietary instructions has a significant impact on the quality 
of bowel preparation.24Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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The adenoma detection rate (ADR) was developed as a 
quality indicator in 2002.9 It has been validated as a powerful 
predictor of CRC risk after screening colonoscopy.25 A recent 
study by Baxter (2009) found that patients colonoscoped by 
doctors with polypectomy rates of 25%–29% and $30% 
had 52% and 39% lower incidence rates, respectively, of 
subsequent proximal colon cancers compared with patients 
colonoscoped by doctors with polypectomy rates #10%.26 
The ASGE/ACG recommendations propose that adenomas 
should be detected in more than 25% of the asymptomatic 
male individuals (.50 years) and in more than 15% of 
the asymptomatic female individuals (.50 years) at first 
colonoscopy because prevalence rates of adenomas in 
colonoscopy screening studies have been consistently over 
25% in men and 15% in women .50 years old.14 The Bowel 
Cancer Screening Program (BCSP) in the UK requires an 
ADR of 35%.27 ADR is cumbersome to calculate as it needs 
to be correlated with pathology data not readily available at 
the time of the procedure. There have been recent studies 
that show that PDR is a useful quality measure with a good 
correlation with the ADR. In a study by Williams et al, the 
PDRs by endoscopists correlated well with their ADRs 
(rs) = 0.86, P , 0.001). To attain the established benchmark 
ADRs for men (25%) and women (15%), endoscopists 
needed PDRs of 40% and 30%, respectively. 28 In our study, 
we used the PDR as a surrogate marker of the ADR and we 
were able to fulfill the requirements of this recently defined 
benchmark (44% for men and 25% for women). Despite 
our suboptimal cecal intubation rate and quality of bowel 
preparation, does our good PDR mean that we are doing 
these fairly well? It is known that adenoma detection is 
dependent on many different variables. Firstly, the baseline 
demographic features of the population screened, such as 
male sex and age above 50 years and to a lesser extent family 
history of colorectal neoplasia, influence the ADR. Secondly, 
factors related to the technique of the examination – such 
as the speciality of the endoscopist (gastroenterologist vs 
non-gastroenterologist),29,30 quality of bowel preparation, and 
withdrawal time – also influence the ADR. Withdrawal times 
are directly linked to ADRs, because a more careful inspection 
leads to a greater yield. Studies have demonstrated increased 
detection of significant neoplastic lesions in colonoscopic 
examinations where the withdrawal time is 6 minutes or 
more.31 In our study, none of the endoscopists reported 
withdrawal times, which can be seen as a major limitation. 
However, nowadays it is recognized that endoscopists who 
meet the ADR benchmark are likely to have satisfactory 
withdrawal technique. Our results regarding gender, age, and 
quality of bowel preparation as influencing factors for PDR 
are in accordance with the published literature. We did not 
find a significant difference in PDR between examinations 
with sedation or without sedation.
Our study has several limitations, as already pointed 
out. Being a retrospective study, there was missing data 
regarding some of the most important quality indicators, such 
as withdrawal time, standardized description of the quality 
of bowel preparation, and the adenoma detection rate. The 
only clear quality indicator we documented was the cecal 
intubation rate. With this data, we acknowledge that the 
assessment of the quality of screening colonoscopies in our 
center is limited and it cannot be extrapolated nationwide. 
Nevertheless, it is the first study in our country where to date 
a national colonoscopy screening program for colorectal 
cancer has not been implemented. Our study provides crucial 
input for improving the quality of our examinations and 
highlights the need to implement the use and the systematic 
report of these quality benchmarks before establishing a 
screening program.
Conclusion
Although colonoscopy screening has been documented to 
confer a high degree of protection against CRC in clinical 
trials, its population-based field efficacy is dependent on 
a high-quality procedure. Several quality indicators have 
been validated and incorporated in screening programs 
worldwide. In our center some of these quality indicators 
are still suboptimal. In the future we should aim to improve 
the quality of our examinations. Future research should be 
directed at determining the best way to use these quality 
indicators for colonoscopy in a manner that results in 
improved patient care and outcome.
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